Y-Biologics (XKRX:338840) Total Stockholders Equity : ₩22,372 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Total Stockholders Equity?

Y-Biologics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩22,372 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Y-Biologics's Book Value per Share for the quarter that ended in Mar. 2024 was ₩1,515.42. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Y-Biologics's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.04.

Y-Biologics Total Stockholders Equity Historical Data

The historical data trend for Y-Biologics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Total Stockholders Equity Chart

Y-Biologics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

16,160.09

7,226.53

30,530.47

28,441.33

12,293.17

Y-Biologics Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial				10,209.72	8,242.80	7,771.89	23,408.46	22,371.71

Y-Biologics (XKRX:338840) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Y-Biologics's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(22371.707	-	0)	/	14.7627
	=	1,515.42

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Y-Biologics's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(180.1	+	689.604)	/	22371.707
	=	0.04

Y-Biologics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR

Website

https://www.ybiologics.com

Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines